The DOI matches its Crossref record; 80 of the 80 references it cites were found in a registry or an index.
Quality of life after treatment for prostate cancer
Abstract
Quality of life is a major concern of patients when they are choosing treatment for prostate cancer. Health-related quality of life is a patient-centered variable from the field of health services research that can be measured in a valid and reliable manner. Using standardized questionnaires specifically developed to capture health-related quality of life data in men with prostate cancer, the effect of treatments on patients' quality of life can be studied. Patients with localized disease who are undergoing radical prostatectomy tend to have more sexual and urinary dysfunction than men undergoing external beam radiation therapy, although both groups have more impairment in these areas than age-matched controls. Men undergoing external beam radiation therapy have worse bowel function and more urinary distress from irritative voiding symptoms than men undergoing radical prostatectomy or age-matched controls. Recent studies of men undergoing interstitial brachytherapy indicate that these patients have less urinary leakage than those who undergo radical prostatectomy, but experience considerably more irritating voiding symptoms, which often profoundly affect their quality of life. Better information regarding the potential impact of prostate cancer treatment on quality of life will improve medical decision-making.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For early stage cancer, primary treatment options are radical prostatectomy, radiation therapy, and active surveillance, which can lead to differences in specific areas of functioning, such as sexual, urinary or bowel functioning over time [2, 3].”
From Prostate cancer: Psychosocial implications and management (2008) · cites this paper as [2]
Citations
Cites
(1992) · PubMed · Cited by 33,716
The MOS 36-ltem Short-Form Health Survey (SF-36): I. Conceptual Framework and Item Selection
Ware, J. E., & Sherbourne, C. D. (1992) · Medical Care · doi:10.1097/00005650-199206000-00002 · Cited by 30,033
WARE, J. E., KOSINSKI, M., & KELLER, S. D. (1996) · Medical Care · doi:10.1097/00005650-199603000-00003 · Cited by 17,392 · cited 1×
“Because the disease-specific domains of the EPIC instrument include significantly more items than the original UCLA PCI, its authors recommend administering it along with the 12-item RAND SF-12 [13] instead of the SF-36 to measure general HRQOL.”
MethodAaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., Filiberti, A., Flechtner, H., Fleishman, S. B., Haes, J. C. J. M. D., et al. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.5.365 · Cited by 16,005
Jemal, A., Murray, T., Samuels, A., Ghafoor, A., Ward, E., & Thun, M. J. (2003) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.53.1.5 · Cited by 3,275
Wilson, I. B. (1995) · JAMA · doi:10.1001/jama.1995.03520250075037 · Cited by 3,027
Wei, J. T., Dunn, R. L., Litwin, M. S., Sandler, H. M., & Sanda, M. G. (2000) · Urology · doi:10.1016/s0090-4295(00)00858-x · Cited by 1,520 · cited 1×
“[12] modified the UCLA PCI, adding 30 items to the disease-specific domains, for a total of 50 items.”
MethodSelf-citationMessing, E. M., Manola, J., Sarosdy, M., Wilding, G., Crawford, E. D., & Trump, D. (1999) · New England Journal of Medicine · doi:10.1056/nejm199912093412401 · Cited by 1,191
Quality-of-life outcomes in men treated for localized prostate cancer
Litwin, M. S., Hays, R. D., Fink, A., Ganz, P. A., Leake, B., Leach, G. E., & Brook, R. H. (1995) · JAMA · doi:10.1001/jama.1995.03520260051032 · Cited by 1,020
Self-citationStanford, J. L., Feng, Z., Hamilton, A. S., Gilliland, F. D., Stephenson, R. A., Eley, J. W., Albertsen, P. C., Harlan, L. C., & Potosky, A. L. (2000) · JAMA · doi:10.1001/jama.283.3.354 · Cited by 956
Research works printed but not linked: 1
- Stanford JL, Stephenson RA, Coyle LM, et al.:Prostate Cancer Trends 1973–1995, SEER Program. Bethesda: National Cancer Institute; 1999.
Cited by
Miller, D. C., Sanda, M. G., Dunn, R. L., Montie, J. E., Pimentel, H., Sandler, H. M., McLaughlin, W. P., & Wei, J. T. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.07.116 · Cited by 383
Frank, S. J., Pisters, L. L., Davis, J. W., Lee, A. K., Bassett, R., & Kuban, D. A. (2007) · The Journal of Urology · doi:10.1016/j.juro.2007.01.134 · Cited by 145
Intensity-Modulated Radiation Therapy: Supportive Data for Prostate Cancer
Cahlon, O., Hunt, M. A., & Zeléfsky, M. J. (2008) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2007.09.007 · Cited by 144
Quality of Life in Prostate Cancer Patients Taking Androgen Deprivation Therapy
Dacal, K., Sereika, S. M., & Greenspan, S. L. (2005) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2005.00567.x · Cited by 137
Prostate cancer: Psychosocial implications and management
Roth, A. J., Weinberger, M. I., & Nelson, C. J. (2008) · Future Oncology · doi:10.2217/14796694.4.4.561 · Cited by 113
“For early-stage cancer, primary treatment options are radical prostatectomy, radiation therapy and active surveillance, which can lead to differences in specific areas of functioning, such as sexual, urinary or bowel functioning, over time [2,3].”
Background
Metadata
- Authors
- Penson, D. F., & Litwin, M. S.
- Affiliations
- University of California, Los Angeles (US)
- Venue
- Current Urology Reports
- Published
- 2003-05
- Volume
- 4
- Issue
- 3
- Pages
- 185-195
- ISSN
- 1527-2737 (ISSN-L)
- 1534-6285
- OpenAlex
- W2003895274
- Cited by
- 71
- References
- 78
- Citations by year
- 2026: 1 · 2024: 1 · 2022: 3 · 2021: 1 · 2019: 2 · 2017: 4 · 2016: 2 · 2015: 3 · 2014: 2 · 2013: 5 · 2012: 1
- FWCI
- 0.89
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Current Urology Reports (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Urology › Prostate Cancer Diagnosis and Treatment
- Health Sciences › Medicine › Oncology › Cancer survivorship and care
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Prostate Cancer Treatment and Research
- Keywords
- prostate cancer, health-related quality of life, radical prostatectomy, external beam radiotherapy, interstitial brachytherapy, sexual dysfunction, urinary dysfunction, bowel dysfunction, irritative voiding symptoms, urinary incontinence, localized prostate cancer, patient-centered outcomes
- MeSH terms
- Brachytherapy, Health Status, Humans, Erectile Dysfunction, Intestinal Diseases, Male, Postoperative Complications, Prostatectomy, Prostatic Neoplasms, Quality of Life, Radiotherapy, Urination Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Quality of life after treatment for prostate cancer. https://app.cochat.ai/papers/10.1007/s11934-003-0068-1
- The paper
- Penson, D. F., & Litwin, M. S. (2003). Quality of life after treatment for prostate cancer. Current Urology Reports. https://doi.org/10.1007/s11934-003-0068-1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.